Bailong will build a new production base in Thailand

Shandong Bailong Chuangyuan Bio-tech Co.,Ltd will invest in building a new production base in Thailand, which will include two production lines. Among them, the D-psicose(Allulose) production line can produce D-psicose(Allulose), fructose crystalline, Isomaltulose and other crystallized sugar products; the resistant dextrin production line can jointly produce Prebiotics products,such as fructooligosaccharides, isomaltooligosaccharides.

The total investment amount of the project is expected to be approximately RMB 452 million. The company plans to purchase land in the Prachinburi Industrial Park, Thailand, build new factories and purchase production equipment and supporting facilities to meet project construction needs.

This investment will help reduce production costs, improve profitability, and at the same time reduce tariff levels and avoid trade risks.